One of the seven ongoing trials of accelerated partial breast irradiation (APBI) has concluded that single-dose intraoperative radiotherapy should be considered as an alternative to protracted whole-breast irradiation. With a median follow up of 2 years, such conclusions seem premature. Until the risk and pattern of breast recurrence is reported at longer follow up, TARGIT APBI should remain an experimental approach.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sarin, R. Partial-breast treatment for early breast cancer: emergence of a new paradigm. Nat. Clin. Pract. Oncol. 2, 40–47 (2005).
Mannino, M. & Yarnold, J. Accelerated partial breast irradiation trials: diversity in rationale and design. Radiother. Oncol. 91, 16–22 (2009).
Offersen, B. V., Overgaard, M., Kroman, N. & Overgaard, J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother. Oncol. 90, 1–13 (2009).
Strnad, V. et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int. J. Radiat. Oncol. Biol. Phys. doi:10.1016/ijrobp.2010.01.020.
Vaidya, J. S. et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376, 91–102 (2010).
Azria, D. & Bourgier, C. Partial breast irradiation: new standard for selected patients. Lancet 376, 71–72 (2010).
Baum, H. Homoeopathy waives the rules. Lancet 376, 577 (2010).
Lancet. Protocol 99PRT/47 targeted intraoperative radiotherapy (Targit) for breast cancer [online], (2010).
Nelson, J. C. et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am. J. Surg. 198, 83–91 (2009).
NIHR Health Technology Assessment Programme. TARGIT protocol version 5.0, April 2010 [online], (2010).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Sarin, R. Ultra-targeted APBI using TARGIT—a cautionary note. Nat Rev Clin Oncol 7, 675–676 (2010). https://doi.org/10.1038/nrclinonc.2010.187
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2010.187
